Conventional trial designs offer limited clinical understanding of cholinesterase-inhibitor treatment effects in Alzheimer disease
- PMID: 15703328
- DOI: 10.1176/appi.ajgp.13.2.170
Conventional trial designs offer limited clinical understanding of cholinesterase-inhibitor treatment effects in Alzheimer disease
Comment on
-
Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease.Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):358-69. doi: 10.1176/appi.ajgp.12.4.358. Am J Geriatr Psychiatry. 2004. PMID: 15249273
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
